Renaissance Technologies’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,211,604
| Closed | -$254K | – | 3840 |
|
|
2018
Q3 | $254K | Buy |
1,211,604
+133,200
| +12% | +$27.9K | ﹤0.01% | 3071 |
|
|
2018
Q2 | $280K | Buy |
1,078,404
+56,300
| +6% | +$14.6K | ﹤0.01% | 2988 |
|
|
2018
Q1 | $256K | Buy |
1,022,104
+431,500
| +73% | +$108K | ﹤0.01% | 3124 |
|
|
2017
Q4 | $187K | Sell |
590,604
-89,800
| -13% | -$28.4K | ﹤0.01% | 3148 |
|
|
2017
Q3 | $254K | Buy |
680,404
+548,800
| +417% | +$205K | ﹤0.01% | 2943 |
|
|
2017
Q2 | $112K | Buy |
131,604
+14,800
| +13% | +$12.6K | ﹤0.01% | 3079 |
|
|
2017
Q1 | $371K | Buy |
116,804
+19,200
| +20% | +$61K | ﹤0.01% | 2853 |
|
|
2016
Q4 | $200K | Buy |
97,604
+40,666
| +71% | +$83.3K | ﹤0.01% | 3006 |
|
|
2016
Q3 | $269K | Buy |
56,938
+20,625
| +57% | +$97.4K | ﹤0.01% | 2990 |
|
|
2016
Q2 | $334K | Sell |
36,313
-607
| -2% | -$5.58K | ﹤0.01% | 2919 |
|
|
2016
Q1 | $428K | Buy |
36,920
+1,740
| +5% | +$20.2K | ﹤0.01% | 2884 |
|
|
2015
Q4 | $500K | Buy |
35,180
+5,645
| +19% | +$80.2K | ﹤0.01% | 2738 |
|
|
2015
Q3 | $496K | Sell |
29,535
-13,032
| -31% | -$219K | ﹤0.01% | 2633 |
|
|
2015
Q2 | $804K | Buy |
42,567
+31,417
| +282% | +$593K | ﹤0.01% | 2554 |
|
|
2015
Q1 | $216K | Buy |
11,150
+8,542
| +328% | +$165K | ﹤0.01% | 2865 |
|
|
2014
Q4 | $76K | Buy |
+2,608
| New | +$76K | ﹤0.01% | 2834 |
|